Showing 1 - 3 results of 3 for search 'Ronald A.M. Damhuis', query time: 0.02s Refine Results
  1. 1
    Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry studyResearch in context

    Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nat... by Rolof G.P. Gijtenbeek, Ronald A.M. Damhuis, Anthonie J. van der Wekken, Lizza E.L. Hendriks, Harry J.M. Groen, Wouter H. van Geffen

    Published 2023-04-01
    Get full text
    Article
  2. 2
    A Nationwide Study on the Impact of Routine Testing for <i>EGFR</i> Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on <i>EGFR</i> Mutation Subclasses

    A Nationwide Study on the Impact of Routine Testing for <i>EGFR</i> Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on <i>EGFR</i> Mutation Subclasses by Bart Koopman, Betzabel N. Cajiao Garcia, Chantal C. H. J. Kuijpers, Ronald A. M. Damhuis, Anthonie J. van der Wekken, Harry J. M. Groen, Ed Schuuring, Stefan M. Willems, Léon C. van Kempen

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands

    Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands by Anneloes L. Noordhof, MD, Esther M. Swart, MSc, Ronald A.M. Damhuis, PhD, Lizza E.L. Hendriks, MD, PhD, Peter W.A. Kunst, MD, PhD, Mieke J. Aarts, PhD, Wouter H. van Geffen, MD, PhD

    Published 2023-09-01
    Get full text
    Article

Search Tools: